Chain Drug Review - OraSolv technology
Cima Labs Inc. says OraSolv, its orally disintegrating drug delivery technology, will be incorporated in a version of Schering-Plough Corp.’s Clarinex Reditabs. Schering recently received FDA approval to market the product. The tablets disintegrate on the tongue without chewing or the need forwater.
Related Results
Clarinex clearedSchering readies Clarinex launchClarinex syrup approved for childrenClarinex Indicated for Young ChildrenBattle over Clarinex switch
COPYRIGHT 2005 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
